LISANDRA ALEXANDRINY: Open Payments
NPI 1518599141 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,562 in 82 payments from 11 companies in 2025. Trend: 2023 $885 · 2024 $356 · 2025 $1,562
Food & beverage: $1,451Education: $111
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 18 | $282 |
| Teva Pharmaceuticals USA, Inc. | 12 | $282 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $260 |
| Alkermes, Inc. | 8 | $175 |
| ABBVIE INC. | 9 | $171 |
| Axsome Therapeutics, Inc. | 7 | $149 |
| Lundbeck LLC | 3 | $77 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $62 |
| Almatica Pharma LLC | 3 | $50 |
| Janssen Pharmaceuticals, Inc | 1 | $35 |
Products named: REXULTI, CAPLYTA, ARISTADA, VRAYLAR, AUSTEDO XR, Auvelity, TRINTELLIX, LOREEV XR.
Industry payments across FL — which companies pay providers there.
